Treatment of Asthma: The long-acting beta-2-agonists

Bibliographic Details
Other Authors: Kummer, Friedrich (Editor)
Format: eBook
Language:English
Published: Vienna Springer Vienna 1998, 1998
Edition:1st ed. 1998
Subjects:
Online Access:
Collection: Springer Book Archives -2004 - Collection details see MPG.ReNa
Table of Contents:
  • Molecular regulation of the ?2-adrenergic receptor by long- and short-acting ?-agonists
  • Molecular interactions between glucocorticoids and ?2-agonists
  • Formoterol, a new long-acting ?2-agonist
  • Development of the long-acting ?2-agonist, salmeterol
  • Development of bambuterol; a long acting, orally active beta-agonist prodrug
  • Development of ?2-receptors in infancy and childhood
  • Long-acting beta-agonists in exercise induced asthma
  • Salmeterol and oral steroid treatment
  • Salmeterol and its relationship to treatment with inhaled corticosteroids
  • Long term treatment with formoterol
  • Comparison of efficiency of bambuterol and salmeterol
  • The future of relievers and controllers in asthma therapy